{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T21:58:22Z","timestamp":1778968702800,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.pop.2012.11.008","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T06:16:02Z","timestamp":1356156962000},"page":"179-194","source":"Crossref","is-referenced-by-count":20,"title":["Hypertension"],"prefix":"10.1016","volume":"40","author":[{"given":"Katherine H.","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Viera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pop.2012.11.008_bib1","first-page":"103","article-title":"Vital signs: prevalence, treatment, and control of hypertension \u2014 United States, 1999\u20132002 and 2005\u20142008","volume":"60","author":"Centers for Disease Control (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.pop.2012.11.008_bib2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2012.11.008_bib3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pop.2012.11.008_bib4","doi-asserted-by":"crossref","first-page":"JC1","DOI":"10.7326\/0003-4819-157-2-201207170-02008","article-title":"Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure","volume":"157","author":"Singh","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2012.11.008_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-147-11-200712040-00009","article-title":"Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"147","author":"U.S. Preventive Services Task Force","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pop.2012.11.008_bib6","series-title":"Essentials of family medicine","first-page":"125","article-title":"Hypertension","author":"Forrest","year":"2011"},{"key":"10.1016\/j.pop.2012.11.008_bib7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age and older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2012.11.008_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0828-282X(07)70798-5","article-title":"The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 \u2013 therapy","volume":"23","author":"Khan","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pop.2012.11.008_bib9","first-page":"1019","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet","volume":"135","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2012.11.008_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/080370500448650","article-title":"Substituting lifestyle management for pharmacological control of blood pressure: a pilot study in Australian general practice","volume":"9","author":"Reid","year":"2000","journal-title":"Blood Press"},{"issue":"6 2ndary Stroke Prevention","key":"10.1016\/j.pop.2012.11.008_bib11","first-page":"1233","article-title":"Blood pressure reduction in secondary stroke prevention","volume":"17","author":"Qureshi","year":"2011","journal-title":"Continuum (Minneapolis Minn)"},{"key":"10.1016\/j.pop.2012.11.008_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.pop.2012.11.008_bib13","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2012.11.008_bib14","first-page":"179","article-title":"Cerebral small vessel disease, cognitive impairment and vascular dementia","volume":"54","author":"Sierra","year":"2012","journal-title":"Panminerva Med"},{"key":"10.1016\/j.pop.2012.11.008_bib15","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/bjo.2005.072546","article-title":"Hypertensive retinopathy revisited: some answers, more questions","volume":"89","author":"Grosso","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pop.2012.11.008_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pop.2012.11.008_bib17","unstructured":"U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Revised May 2005. Available at: http:\/\/www.nhlbi.nih.gov\/health\/prof\/heart\/hbp\/hbp_ped.pdf. Accessed August 27, 2012."},{"key":"10.1016\/j.pop.2012.11.008_bib18","first-page":"1471","article-title":"Secondary hypertension: an age-based approach","volume":"82","author":"Viera","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2012.11.008_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/02841850600849092","article-title":"A\u00a0prospective comparison of duplex ultrasonagraphy, captopril renography, MRA, and CTA in assessing renal artery stenosis","volume":"47","author":"Eklof","year":"2006","journal-title":"Acta Radiol"},{"key":"10.1016\/j.pop.2012.11.008_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.semnephrol.2011.06.008","article-title":"Infection-related glomerulonephritis: understanding mechanisms","volume":"31","author":"Nadasdy","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.pop.2012.11.008_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00467-012-2104-1","article-title":"Screening high-grade vesicoureteral reflux in young infants with a febrile urinary tract infection","volume":"27","author":"Tsai","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pop.2012.11.008_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jvs.2011.09.006","article-title":"Short- and long-term outcomes of percutaneous transluminal angioplasty\/stenting of renal fibromuscular dysplasia over a ten-year period","volume":"55","author":"Mousa","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.pop.2012.11.008_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jvs.2010.10.066","article-title":"Diagnosis, management, and future developments of fibromuscular dysplasia","volume":"53","author":"Olin","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"issue":"11","key":"10.1016\/j.pop.2012.11.008_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.106.173994","article-title":"ACC\/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pop.2012.11.008_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CRD.0b013e31824a72e9","article-title":"Revascularization in renal-artery stenosis","volume":"20","author":"Foy","year":"2012","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.pop.2012.11.008_bib26","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization versus medical therapy for renal-artery stenosis","volume":"361","author":"Wheatley","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2012.11.008_bib27","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pop.2012.11.008_bib28","doi-asserted-by":"crossref","first-page":"837817","DOI":"10.4061\/2011\/837817","article-title":"Aldosteronism and resistant hypertension","volume":"2011","author":"Acelajado","year":"2011","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.pop.2012.11.008_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pop.2012.11.008_bib30","first-page":"325","article-title":"The variability of measurements of casual blood pressure: a laboratory study","volume":"30","author":"Armitage","year":"1966","journal-title":"Clin Sci"},{"key":"10.1016\/j.pop.2012.11.008_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00126097-200212000-00001","article-title":"What is the white-coat effect and how should it be measured?","volume":"7","author":"Pickering","year":"2002","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.pop.2012.11.008_bib32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/ajh.2010.158","article-title":"Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring","volume":"23","author":"Viera","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pop.2012.11.008_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.amjhyper.2006.12.011","article-title":"Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage","volume":"20","author":"Shimbo","year":"2007","journal-title":"Am J Hypertens"},{"issue":"8","key":"10.1016\/j.pop.2012.11.008_bib34","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.hjh.0000239289.87141.b6","article-title":"The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings","volume":"24","author":"Verberk","year":"2006","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.pop.2012.11.008_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MBP.0b013e32830263b7","article-title":"How and why do patients use home blood pressure monitors?","volume":"13","author":"Viera","year":"2008","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.pop.2012.11.008_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.38121.684410.AE","article-title":"Blood pressure control by home monitoring: meta-analysis of randomized trials","volume":"329","author":"Cappuccio","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2012.11.008_bib37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-hour blood pressure: the Ohasama study","volume":"20","author":"Ohkubo","year":"2002","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.pop.2012.11.008_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.282.6.539","article-title":"Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension","volume":"282","author":"Staessen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2012.11.008_bib39","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","article-title":"Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study","volume":"107","author":"Kario","year":"2003","journal-title":"Circulation"},{"issue":"e-supplement A","key":"10.1016\/j.pop.2012.11.008_bib40","first-page":"e426","article-title":"Automated office blood pressure recorded at one minute intervals","volume":"29","author":"Myers","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.pop.2012.11.008_bib41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/fampra\/cmr113","article-title":"Conventional versus automated measurement of blood pressure in the office (CAMBO) trial","volume":"29","author":"Myers","year":"2012","journal-title":"Fam Pract"},{"key":"10.1016\/j.pop.2012.11.008_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2261-5-18","article-title":"The BpTRU automatic blood pressure monitor compared to 24-h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension","volume":"5","author":"Beckett","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.pop.2012.11.008_bib43","unstructured":"U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults, topic page. June 2008. Available at: http:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/uspsdiab.htm. Accessed December 8, 2012."},{"key":"10.1016\/j.pop.2012.11.008_bib44","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2010.04.003","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes. American Diabetes Association; American Heart Association; American College of Cardiology Foundation","volume":"55","author":"Pignone","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.pop.2012.11.008_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pop.2012.11.008_bib46","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2012.11.008_bib47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicenter, randomized, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2012.11.008_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ajh.2010.189","article-title":"The contribution of hypertension to black-white differences in likelihood of coronary artery disease detected during elective angiography","volume":"24","author":"Triplette","year":"2011","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.pop.2012.11.008_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1751-7176.2011.00568.x","article-title":"Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","volume":"14","author":"Cushman","year":"2012","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.pop.2012.11.008_bib50","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(02)70054-1","article-title":"National Kidney Foundation Guideline. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pop.2012.11.008_bib51","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2012.11.008_bib52","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results of the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pop.2012.11.008_bib53","series-title":"USRDS 2007 Annual data report","author":"United States Renal Data System","year":"2007"},{"key":"10.1016\/j.pop.2012.11.008_bib54","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pop.2012.11.008_bib55","first-page":"863","article-title":"Evaluation and management of the patient with difficult-to-control or resistant hypertension","volume":"79","author":"Viera","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2012.11.008_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.pop.2012.11.008_bib57","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial monotherapy and combination therapy and hypertension control the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.pop.2012.11.008_bib58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pop.2012.11.008_bib59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/HYPERTENSIONAHA.111.181248","article-title":"Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial","volume":"58","author":"Ernst","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pop.2012.11.008_bib60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","article-title":"Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis","volume":"57","author":"Dorsch","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pop.2012.11.008_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454312001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454312001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:57:59Z","timestamp":1745938679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454312001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0095454312001042"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2012.11.008","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}